- Home
- EIC vs XBIT Comparison
EIC vs XBIT Comparison
Compare EIC & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EIC | XBIT |
|---|---|---|
| Founded | N/A | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Pharmaceuticals and Biotechnology |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 293.8M | 73.2M |
| IPO Year | 2019 | 2015 |
Fundamental Metrics
Financial Performance| Metric | EIC | XBIT |
|---|---|---|
| Price | $11.50 | $2.33 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | ★ 280.4K | 59.4K |
| Earning Date | 02-19-2026 | 11-12-2025 |
| Dividend Yield | ★ 13.79% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.14 | N/A |
| Revenue | ★ $59,262,402.00 | N/A |
| Revenue This Year | $37.84 | N/A |
| Revenue Next Year | $23.33 | N/A |
| P/E Ratio | $9.95 | ★ N/A |
| Revenue Growth | ★ 44.30 | N/A |
| 52 Week Low | $10.81 | $2.09 |
| 52 Week High | $16.39 | $4.67 |
Technical Indicators
Market Signals| Indicator | EIC | XBIT |
|---|---|---|
| Relative Strength Index (RSI) | 53.19 | 45.22 |
| Support Level | $11.20 | $2.40 |
| Resistance Level | $11.44 | $2.55 |
| Average True Range (ATR) | 0.24 | 0.11 |
| MACD | 0.08 | -0.01 |
| Stochastic Oscillator | 91.77 | 12.12 |
Price Performance
Historical ComparisonAbout EIC Eagle Point Income Company Inc.
Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.